TWIST1 and acute myeloid leukemia: In contrast, a second study determined that enforced TWIST1 overexpression in two independent AML cell lines (U937 and K562) led to increased resistance to daunorubicin, mitoxantrone or imatinib, and subsequently found that high TWIST1 in AML samples was associated with a worse overall survival (146).